Pharmaceutically acceptable starch

US6689389B2 · kind B2 · utility

Assignee

• JAGOTEC AG · CH

Inventors

• Nils Ove Gustavsson · Bjärred, SE
• Monica Jonsson · Bara, SE
• Per Berden · Malmö, SE
• Timo Laakso · Campton, GB
• Mats Reslow · Lund, SE

Key dates

• Filing date: Oct 5, 2001
• Grant date: Feb 10, 2004
• Expiry date: Oct 5, 2021

Classification

• Technology area (CPC Y): Emerging Cross-Sectional Technologies
• CPC primary: Y10T428/2991
• WIPO field: Pharmaceuticals
• WIPO sector: Chemistry

Abstract

Production of purified, parenterally administrable starch by washing starch containing more than 85% amylopectin in order to remove surface-localized proteins, lipids and endotoxins, dissolving the starch in aqueous medium, molecular weight reduction by shearing, and optionally removal of residual water-soluble proteins, preferably by anion exchange chromatography.Purified starch and microparticles based on such starch.